Bioinnovo participated in the XIV Argentine Congress of Virology 2026, held from May 27 to 29 at the UCA Auditorium in Puerto Madero, Buenos Aires, consolidating its presence in one of the region’s premier scientific forums for exchange and updates in virology. Under the…
On November 27, the 12th edition of BioArgentina was held in Paraná, Entre Ríos. As the country’s premier biotechnology forum, the event was organized by the Argentine Chamber of Biotechnology (CAB). The gathering brought together researchers, startups, leading corporations, entrepreneurs, and public sector representatives, consolidating…
Within the framework of the NANOBIOTEC seminar series, Biochemist Hernán Ramírez, a member of the Bioinnovo team, presented his research titled “Design and evaluation of vaccine strategies for cattle against enterohemorrhagic Escherichia coli O157:H7, the causative agent of Hemolytic Uremic Syndrome in humans.” The…
INTA, the National Research Council of Canada (NRCC), and Bioinnovo—a technology-based company established jointly by INTA and Vetanco SA—are currently developing the first vaccine against the foot-and-mouth disease virus (FMDV) that completely eliminates the use of infective material in its manufacturing process. This achievement represents…
NRCC (Canada), INTA, and Bioinnovo were awarded in the “Concurso Soluciones Innovadoras EMPRETEC BNA 2024”, for the development of an innovative vaccine for preventing the aphthous fever. Among more than 1,500 applicants, the project developed jointly by the National Research Council of Canada (NRCC) and…
“We must take a three-pronged approach to address the problem: diagnosis, prevention through vaccination and biosecurity of facilities”. Said by Dr. Paul Walz, of the College of Veterinary Medicine at Auburn University, Alabama, in the United States, during the 3rd International Congress of Bovine Viral Diarrhea Virus (BVDV) organized…
At this year’s event, which will be held under the theme “Impact and Management of BVD Virus in Cattle,” international experts will discuss strategies to control this disease and mitigate its impact on livestock. Next August 28 at 6:00 PM, the 3rd International Congress on Bovine Viral Diarrhea…
The world’s first targeted vaccine against the Bovine Viral Diarrhea Virus (BVDV), developed by Bioinnovo, was one of 4 finalists in its category among around 1,000 projects submitted at the 13th edition of the Pioneering Solutions Contest from Banco Nación, aimed at SMEs and enterprises….
Knowledge about the impact of this virus on production and control measures to mitigate its effect on the herd was disseminated at the Second International Congress on Bovine Viral Diarrhea Virus (BVDV), convened by Bioinnovo and INTA. The Second International BVDV Congress, held virtually by…
In August, Bioinnovo will host the Second International Congress on Bovine Viral Diarrhea Virus (BVDV), which will be held remotely. Bioinnovo, the public-private company made up of Vetanco and INTA, will host the Second International Congress on BVDV, which will be held online on Monday,…